Technology ❯ Biotechnology

Genetic Testing

Data Privacy Consumer Products Data Security DNA Sequencing Consumer Genetics Data Management 23andMe Cell-Free DNA Next-Generation Sequencing Epigenetic Tools Illumina Personalized Medicine Direct-to-Consumer Services User Data Management Investigative Genetic Genealogy DNA Data Gene Sequencing DNA Analysis Consumer Technology DNA Profiling Whole Genome Sequencing Forensic Applications Machine Learning Algorithms Animal Genetics Pharmacogenetics Genealogy Databases

VolitionRx Reports >99% Tumor DNA Purity With ‘Capture-Seq’

Results remain preliminary pending peer review, with larger independent studies expected.

BillionToOne Soars in Nasdaq Debut After Upsized $273 Million IPO

Wojcicki’s Nonprofit Tops Regeneron With $305M Bid for 23andMe